Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

Sector

Healthcare Facilities & Services

More about the company

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	56.67M 65.61M 52.22M 48.88M 91.61M 6.24B 93.03M 617M 240M 3.04B 246M 241M 10.51B	P/E Ratio 2024	44.3x	P/E Ratio 2025	31.3x
Enterprise Value	56.79M 65.76M 52.34M 48.99M 91.81M 6.25B 93.23M 618M 241M 3.04B 247M 242M 10.53B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
18/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
04-01	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
01-19	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

06-12	Klea Holding : Déclaration des transactions sur actions propres
06-11	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
06-11	Klea Holding annonce le démarrage de sa nouvelle filiale
06-11	Une bonne grosse purge avant SpaceX
06-11	Klea Holding : Klea Pharmaceuticals annonce le démarrage de son activité avec un puissant partenaire

VISD GP Share Price Swiss Exchange

Stocks

OXVMG

FR0011067669

Healthcare Facilities & Services

Valuation: VISD GP

Latest news : VISD GP

Analysts' recommendations: VISD GP

Press Releases: VISD GP

News in other languages: VISD GP

Managers and Directors: VISD GP

Other Healthcare Facilities & Services

Financials

Company Profile

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CVS HEALTH CORPORATION	+1.47%	+6.29%	+51.14%	+41.10%	130B
HCA HEALTHCARE, INC.	+2.29%	+4.04%	+4.31%	+38.35%	85.89B
FRESENIUS SE & CO. KGAA	+1.13%	+1.10%	-14.39%	+48.66%	24.57B
QUEST DIAGNOSTICS INCORPORATED	-0.38%	+1.38%	+12.68%	+48.53%	22.48B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+1.69%	+0.32%	-14.00%	-19.33%	19.83B
TENET HEALTHCARE CORPORATION	+0.86%	+7.77%	+6.26%	+131.12%	15.04B
REDE D'OR SÃO LUIZ S.A.	+0.12%	+4.03%	-2.91%	+5.64%	14.78B
DAVITA INC.	+2.37%	+8.59%	+53.29%	+112.40%	13.4B
FRESENIUS MEDICAL CARE AG	+2.51%	+3.90%	-20.47%	-6.57%	12.34B
Average	+1.34%	+3.97%	+8.44%	+44.43%	37.6B
Weighted average by Cap.	+1.53%	+4.54%	+21.25%	+41.44%

	2024	2025
Net sales	17.26M 19.98M 15.91M 14.89M 27.9M 1.9B 28.33M 188M 73.22M 925M 75M 73.4M 3.2B	22.17M 25.66M 20.43M 19.12M 35.83M 2.44B 36.39M 241M 94.04M 1.19B 96.32M 94.27M 4.11B
Net income	1.4M 1.63M 1.29M 1.21M 2.27M 155M 2.31M 15.29M 5.96M 75.26M 6.11M 5.98M 261M	2.28M 2.64M 2.1M 1.97M 3.69M 251M 3.74M 24.82M 9.68M 122M 9.91M 9.7M 423M
Net Debt	2.58M 2.98M 2.37M 2.22M 4.16M 283M 4.23M 28.02M 10.92M 138M 11.19M 10.95M 478M	125K 145K 115K 108K 202K 13.76M 205K 1.36M 530K 6.7M 543K 532K 23.18M

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-